Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 23390942)

1.

Vitamin A: yet another player in multiple sclerosis pathogenesis?

Filippi M, Preziosa P, Rocca MA.

Expert Rev Clin Immunol. 2013 Feb;9(2):113-5. doi: 10.1586/eci.12.105.

PMID:
23390942
2.

Vitamin D and multiple sclerosis: review of a possible association.

Summerday NM, Brown SJ, Allington DR, Rivey MP.

J Pharm Pract. 2012 Feb;25(1):75-84. doi: 10.1177/0897190011421839. Review.

PMID:
21987526
3.

Vitamin D for the management of multiple sclerosis.

Jagannath VA, Fedorowicz Z, Asokan GV, Robak EW, Whamond L.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008422. doi: 10.1002/14651858.CD008422.pub2. Review.

PMID:
21154396
4.

Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?

Pierrot-Deseilligny C, Souberbielle JC.

Brain. 2010 Jul;133(Pt 7):1869-88. doi: 10.1093/brain/awq147. Review.

6.

Clinical implications of a possible role of vitamin D in multiple sclerosis.

Pierrot-Deseilligny C.

J Neurol. 2009 Sep;256(9):1468-79. doi: 10.1007/s00415-009-5139-x. Epub 2009 Apr 28. Review.

7.

Vitamin D treatment in multiple sclerosis.

Myhr KM.

J Neurol Sci. 2009 Nov 15;286(1-2):104-8. doi: 10.1016/j.jns.2009.05.002. Epub 2009 Jun 23. Review.

PMID:
19549608
8.

[Subcutaneous interferon-beta-1a in the treatment of multiple sclerosis].

Fertl E, Krichmayr M.

Wien Med Wochenschr. 2008;158(3-4):98-109. doi: 10.1007/s10354-008-0510-6. Review. German.

PMID:
18330526
9.

What is new in the treatment of multiple sclerosis?

Weinstock-Guttman B, Jacobs LD.

Drugs. 2000 Mar;59(3):401-10. Review.

PMID:
10776827
10.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
11.

The role of vitamin D in multiple sclerosis.

Kampman MT, Steffensen LH.

J Photochem Photobiol B. 2010 Nov 3;101(2):137-41. doi: 10.1016/j.jphotobiol.2010.04.003. Epub 2010 Apr 21. Review.

PMID:
20471852
12.

Vitamin D and its immunoregulatory role in multiple sclerosis.

Niino M.

Drugs Today (Barc). 2010 Apr;46(4):279-90. doi: 10.1358/dot.2010.46.4.1476498. Review.

PMID:
20502725
13.

Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta.

Comi G.

Clin Ther. 2009 Jun;31(6):1142-57. doi: 10.1016/j.clinthera.2009.06.007. Review.

PMID:
19695384
14.

Teriflunomide for multiple sclerosis.

He D, Xu Z, Dong S, Zhang H, Zhou H, Wang L, Zhang S.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD009882. doi: 10.1002/14651858.CD009882.pub2. Review.

PMID:
23235682
15.

Multiple sclerosis, osteoporosis, and vitamin D.

Sioka C, Kyritsis AP, Fotopoulos A.

J Neurol Sci. 2009 Dec 15;287(1-2):1-6. doi: 10.1016/j.jns.2009.09.012. Epub 2009 Oct 2. Review.

PMID:
19800081
16.

Therapeutic potential of vitamin D for multiple sclerosis.

Niino M, Fukazawa T, Kikuchi S, Sasaki H.

Curr Med Chem. 2008;15(5):499-505. Review.

PMID:
18289005
17.

Vitamin D: a natural inhibitor of multiple sclerosis.

Hayes CE.

Proc Nutr Soc. 2000 Nov;59(4):531-5. Review.

PMID:
11115787
18.

Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics.

Simon KC, Munger KL, Ascherio A.

Curr Opin Neurol. 2012 Jun;25(3):246-51. doi: 10.1097/WCO.0b013e3283533a7e. Review.

PMID:
22547098
19.

The emerging role of vitamin D binding protein in multiple sclerosis.

Disanto G, Ramagopalan SV, Para AE, Handunnetthi L.

J Neurol. 2011 Mar;258(3):353-8. doi: 10.1007/s00415-010-5797-8. Epub 2010 Nov 2. Review.

PMID:
21042807
20.

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, Strasser-Fuchs S, Vass K, Altenkirch H, Bamborschke S, Baum K, Benecke R, Brück W, Dommasch D, Elias WG, Gass A, Gehlen W, Haas J, Haferkamp G, Hanefeld F, Hartung HP, Heesen C, Heidenreich F, Heitmann R, Hemmer B, Hense T, Hohlfeld R, Janzen RW, Japp G, Jung S, Jügelt E, Koehler J, Kölmel W, König N, Lowitzsch K, Manegold U, Melms A, Mertin J, Oschmann P, Petereit HF, Pette M, Pöhlau D, Pohl D, Poser S, Sailer M, Schmidt S, Schock G, Schulz M, Schwarz S, Seidel D, Sommer N, Stangel M, Stark E, Steinbrecher A, Tumani H, Voltz R, Weber F, Weinrich W, Weissert R, Wiendl H, Wiethölter H, Wildemann U, Zettl UK, Zipp F, Zschenderlein R, Izquierdo G, Kirjazovas A, Packauskas L, Miller D, Koncan Vracko B, Millers A, Orologas A, Panellus M, Sindic CJ, Bratic M, Svraka A, Vella NR, Stelmasiak Z, Selmaj K, Bartosik-Psujik H, Mitosek-Szewczyk K, Belniak E, Mochecka A, Bayas A, Chan A, Flachenecker P, Gold R, Kallmann B, Leussink V, Mäurer M, Ruprecht K, Stoll G, Weilbach FX; Multiple Sclerosis Therapy Consensus Group.

J Neurol. 2004 Nov;251(11):1329-39. Review.

PMID:
15592728
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk